163 related articles for article (PubMed ID: 8261445)
1. Telomere shortening in renal cell carcinoma.
Mehle C; Ljungberg B; Roos G
Cancer Res; 1994 Jan; 54(1):236-41. PubMed ID: 8261445
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in human renal cell carcinoma.
Mehle C; Piatyszek MA; Ljungberg B; Shay JW; Roos G
Oncogene; 1996 Jul; 13(1):161-6. PubMed ID: 8700542
[TBL] [Abstract][Full Text] [Related]
3. Changes in telomere lengths in renal cell carcinomas.
Dahse R; Fiedler W; Ernst G; Kosmehl H; Schlichter A; Schubert J; Claussen U
Cell Mol Biol (Noisy-le-grand); 1996 Jun; 42(4):477-85. PubMed ID: 8828903
[TBL] [Abstract][Full Text] [Related]
4. Telomere shortening is associated with cell division in vitro and in vivo.
Allsopp RC; Chang E; Kashefi-Aazam M; Rogaev EI; Piatyszek MA; Shay JW; Harley CB
Exp Cell Res; 1995 Sep; 220(1):194-200. PubMed ID: 7664836
[TBL] [Abstract][Full Text] [Related]
5. Multiple pathways to cellular senescence: role of telomerase repressors.
Oshimura M; Barrett JC
Eur J Cancer; 1997 Apr; 33(5):710-5. PubMed ID: 9282109
[TBL] [Abstract][Full Text] [Related]
6. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.
Ducray C; Pommier JP; Martins L; Boussin FD; Sabatier L
Oncogene; 1999 Jul; 18(29):4211-23. PubMed ID: 10435634
[TBL] [Abstract][Full Text] [Related]
7. In vivo regulation of telomerase activity and telomere length.
Hathcock KS; Jeffrey Chiang Y; Hodes RJ
Immunol Rev; 2005 Jun; 205():104-13. PubMed ID: 15882348
[TBL] [Abstract][Full Text] [Related]
8. Regional loss of chromosome 6 in two urological malignancies.
Rukstalis DB; Bubley GJ; Donahue JP; Richie JP; Seidman JG; DeWolf WC
Cancer Res; 1989 Sep; 49(18):5087-90. PubMed ID: 2766279
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
10. Analysis of telomerase activity and telomere function in cancer.
Gordon KE; Parkinson EK
Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
[TBL] [Abstract][Full Text] [Related]
11. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
12. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy.
Healy KC
Oncol Res; 1995; 7(3-4):121-30. PubMed ID: 8555645
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
[TBL] [Abstract][Full Text] [Related]
14. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
15. Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.
Sashida G; Ohyashiki JH; Nakajima A; Sumi M; Kawakubo K; Tauchi T; Ohyashiki K
Clin Cancer Res; 2003 Apr; 9(4):1489-96. PubMed ID: 12684424
[TBL] [Abstract][Full Text] [Related]
16. Telomere repeat fragment sizes do not limit the growth potential of uterine leiomyomas.
Rogalla P; Rohen C; Hennig Y; Deichert U; Bonk U; Bullerdiek J
Biochem Biophys Res Commun; 1995 Jun; 211(1):175-82. PubMed ID: 7779084
[TBL] [Abstract][Full Text] [Related]
17. Genetic changes and telomerase activity in human renal cell carcinoma.
Rohde V; Sattler HP; Oehlenschläger B; Forster S; Zwergel T; Seitz G; Wullich B
Clin Cancer Res; 1998 Jan; 4(1):197-202. PubMed ID: 9516971
[TBL] [Abstract][Full Text] [Related]
18. Telomere reduction and telomerase inactivation during neuronal cell differentiation.
Kruk PA; Balajee AS; Rao KS; Bohr VA
Biochem Biophys Res Commun; 1996 Jul; 224(2):487-92. PubMed ID: 8702416
[TBL] [Abstract][Full Text] [Related]
19. Telomere length dynamics in telomerase-positive immortal human cell populations.
Bryan TM; Englezou A; Dunham MA; Reddel RR
Exp Cell Res; 1998 Mar; 239(2):370-8. PubMed ID: 9521855
[TBL] [Abstract][Full Text] [Related]
20. Control of telomere length by the human telomeric protein TRF1.
van Steensel B; de Lange T
Nature; 1997 Feb; 385(6618):740-3. PubMed ID: 9034193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
